Skip to main content

Cardiovascular Drugs and Therapy

Ausgabe 3/2024

Inhalt (31 Artikel)

Editorial

Instent CTO—What Is the Best Treatment Strategy?

Mark Sahyouni, George A. Stouffer

Editorial

Poking and Prodding So They Take Their Pills

Revati Reddy, James C. Blankenship

Invited Editorial

Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte?

Saifei Liu, Indy AJ Lawrie, Bibi Rabia, John D. Horowitz

Invited Editorial

Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes

Arun Samidurai, Rakesh C. Kukreja

Letter to the Editor

C/EBP Homologous Protein: A Potential Therapeutic Target for Atherosclerosis Treatment?

Jinjiao Shan, Sanlong Liu, Ying Liu, Jingguang Zhu

Letter to the Editor

IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area

Yanyan Ye, Fangyuan Chang, Yingchun Xu

Letter to the Editor

The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Open Access COVID-19 Original Article

Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial

Kishal Lukhna, Helison R. P. do Carmo, Alejandro Rossell Castillo, Sean M. Davidson, Hayli Geffen, Sara Giesz, Pelin Golforoush, Ticiane Gonçalez Bovi, Diana Gorag, Alan Salama, Aqeela Imamdin, Siavash Kalkhoran, Sandrine Lecour, Mauricio W. Perroud Jr., Mpiko Ntsekhe, Andrei C. Sposito, Derek M. Yellon

Original Article

Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study

Roy O. Mathew, Mandeep S. Sidhu, Charanjit S. Rihal, Ryan Lennon, Mohammed El-Hajjar, Neil Yager, Radmila Lyubarova, Khaled Abdul-Nour, Steven Weitz, D. Fearghas O’Cochlain, Vishakantha Murthy, Justin Levisay, Kevin Marzo, John Graham, Vlad Dzavik, Derek So, Shaun Goodman, Yves D. Rosenberg, Naveen Pereira, Michael E. Farkouh

Original Article

Left Bundle Branch Area Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy on Morbidity and Mortality

Yixiu Liang, Zilong Xiao, Xi Liu, Jingfeng Wang, Ziqing Yu, Xue Gong, Hongyang Lu, Shengwen Yang, Min Gu, Lei Zhang, Minghui Li, Lei Pan, Xiao Li, Xueying Chen, Yangang Su, Wei Hua, Junbo Ge

Original Article

Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review

Luca A. F. Di Odoardo, Matteo Bianco, Iván J. Núñez Gil, Italo G. Motolese, Alessandra Chinaglia, Marco Vicenzi, Stefano Carugo, Giulio G. Stefanini, Enrico Cerrato

Open Access Original Article

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials

Wolfgang Koenig, Lorena Garcia Conde, Ulf Landmesser, Lawrence A. Leiter, Kausik K. Ray, Gregory G. Schwartz, R Scott Wright, Jackie Han, Frederick J. Raal

Open Access Original Article

Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease

Wei-Chieh Lee, Ting-Wei Liao, Tien-Yu Chen, Hsiu-Yu Fang, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Shang-Hung Chang, Mien-Cheng Chen

Original Article

Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis

Jing Chen, Jin-Qiu Wei, Mo-Na Hong, Zhong Zhang, Han-Dan Zhou, Yuan-Yuan Lu, Jia Zhang, Yue-Tong Guo, Xin Chen, Ji-Guang Wang, Ping-Jin Gao, Xiao-Dong Li

Open Access Original Article

Vaccine Targeting Alpha 1D-Adrenergic Receptor Improved Metabolic Syndrome in Mice

Xin Li, Wenrui Ma, Yanzhao Zhou, Chang Li, Dingyang Shi, Wenlong Kuang, Jiacheng Wu, Yuhua Liao, Zhihua Qiu, Zihua Zhou

Original Article

Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress

Lingxi Zhang, Chenghong Hu, Bo Jin, Bin Bai, Jing Liao, Leiming Jin, Minxiu Wang, Weiwei Zhu, Xuedan Wu, Li Zheng, Xuelian Xu, Yongsheng Jiang, Yi Wang, Ying He

Original Article

IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway

Zhang Qian, Feng Shaofang, Chen Chen, Shi Chunhua, Wang Nan, Liu Chao

Original Article

PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study

Umut Kocabaş, Isil Ergin, Veysel Yavuz, Selda Murat, Ibrahim Özdemir, Ömer Genç, Cihan Altın, Haşim Tüner, Bengisu Keskin Meriç, Ali Çoner, Elif İlkay Yüce, Bedrettin Boyraz, Onur Aslan, Ahmet Dal, Taner Şen, Ersin İbişoğlu, Aslan Erdoğan, Mehmet Özgeyik, Mevlüt Demir, Ziya Gökalp Bilgel, Büşra Güvendi Şengör, Örsan Deniz Urgun, Mustafa Doğduş, Deniz Dilan Naki Tekin, Sinem Çakal, Sercan Çayırlı, Arda Güler, Dilay Karabulut, Onur Dalgıç, Osman Uzman, Bektaş Murat, Şeyda Şahin, Umut Karabulut, Tarık Kıvrak, Muharrem Said Coşgun, Ferhat Özyurtlu, Mehmet Kaplan, Emre Özçalık, Hakan Gökalp Uzun, Süleyman Kalaycı, Gülsüm Bingöl, Özge Özden, Gülsüm Meral Yılmaz Öztekin, Ayça Gümüşdağ, Meltem Altınsoy, Faruk Aydınyılmaz, Mehtap Yeni, Halil İbrahim Biter, Ümit Yaşar Sinan, Veysel Özgür Barış, Özcan Vuran, Sefa Okar

Correction

Correction to: Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants In Patients With Atrial Fibrillation: The ANATOLIA-AF Study

Umut Kocabaş, Isil Ergin, Veysel Yavuz, Selda Murat, Ibrahim Özdemir, Ömer Genç, Cihan Altın, Haşim Tüner, Bengisu Keskin Meriç, Ali Çoner, Elif İlkay Yüce, Bedrettin Boyraz, Onur Aslan, Ahmet Dal, Taner Şen, Ersin İbişoğlu, Aslan Erdoğan, Mehmet Özgeyik, Mevlüt Demir, Ziya Gökalp Bilgel, Büşra Güvendi Şengör, Örsan Deniz Urgun, Mustafa Doğduş, Deniz Dilan Naki Tekin, Sinem Çakal, Sercan Çayırlı, Arda Güler, Dilay Karabulut, Onur Dalgıç, Osman Uzman, Bektaş Murat, Şeyda Şahin, Umut Karabulut, Tarık Kıvrak, Muharrem Said Coşgun, Ferhat Özyurtlu, Mehmet Kaplan, Emre Özçalık

Open Access Review Article

Influence of Genetic and Epigenetic Factors of P2Y12 Receptor on the Safety and Efficacy of Antiplatelet Drugs

Dorota Danielak, Kornel Pawlak, Franciszek Główka, Marta Karaźniewicz-Łada

Review Article

Direct Oral Anticoagulants: Navigating Through Clinical Challenges

Maria Ioannou, Elena Leonidou, Ioanna Chaziri, Angeliki Mouzarou

Short Communication

Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension

Justin K. Lui, Ruchika A. Sangani, Kari R. Gillmeyer, Jasmine Vakhshoorzadeh, Marcin A. Trojanowski, Andreea M. Bujor, Deepa M. Gopal, Renda Soylemez Wiener, Michael P. LaValley, Elizabeth S. Klings

Correction

Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension

Justin K. Lui, Ruchika A. Sangani, Kari R. Gillmeyer, Jasmine Vakhshoorzadeh, Marcin A. Trojanowski, Andreea M. Bujor, Deepa M. Gopal, Renda Soylemez Wiener, Michael P. LaValley, Elizabeth S. Klings

So beeinflussen Herzinfarkte auf lange Sicht die Sterblichkeit

20.06.2024 ST-Hebungsinfarkt Nachrichten

Wie hoch ist bei Patienten, die nach einem ST-Hebungs-Myokardinfarkt die initiale Hochrisikophase überleben, auf lange Sicht das Sterberisiko? Eine Studie aus Dänemark liefert dazu nun aufschlussreiche Daten.

Protonenpumpenhemmer stoppt Arrhythmie

20.06.2024 Protonenpumpenhemmstoffe Nachrichten

Wenn Nervenfasern aus dem Magen und dem Herzen im Gehirn dicht beieinander liegen, kann auch mal etwas schiefgehen: So lässt sich erklären, weshalb Schmerzen durch einen Magentumor bei einem Mann eine ventrikuläre Extrasystolie auslösen – und PPI diese beenden.

Ob Apixaban nützt oder schadet, entscheidet der CHA2DS2-VASc-Score

20.06.2024 Therapie des Vorhofflimmerns Nachrichten

Patienten mit subklinischem Vorhofflimmern tragen ein erhöhtes Risiko für Schlaganfälle. Da stellt sich die Frage nach einer medikamentösen Antikoagulation. Offenbar hängt es aber vom CHA2DS2-VASc-Score ab, ob die Gabe von Apixaban von Vorteil ist.

Wie SGLT2-Hemmer es schaffen, die Mortalität zu reduzieren

20.06.2024 Kardiologische Therapie Nachrichten

SGLT2-Hemmer verhindern keine Herzinfarkte oder Schlaganfälle. Aber sie reduzieren die kardiovaskuläre Mortalität bei einem breiten Spektrum von Patienten. Wie sie das schaffen, verdeutlicht eine Metaanalyse von Daten aus elf randomisierten Studien.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.